In addition, FoxO3a may also be considered an important protective factor in ER+ BCCs [22,23] and a good prognostic factor in Luminal-like BC (ER+ cases) [24] where it directly correlates with biomarkers of good prognosis and with longer BC specific survival. The gene discussed is ESR1; the disease is breast cancer.